Microbiome Relevance to GLP-1 Activity The microbiome is necessary for postprandial increases in GLP-1 secretion, as depletion of the microbiome with antibiotic treatment attenuates the postprandial release of GLP-1 [146]
In November 2024, the Biden administration proposed that Medicare and Medicaid be required to cover GLP-1 drugs for people with obesity
Recent studies have shown that muscle mass loss induced by GLP-1s can account for 1540% of total weight loss (7)
Related Stories Why new Alzheimers drugs are dividing regulators worldwide GLP-1 weight-loss drugs may also reduce binge eating GLP-1 drugs may help curb addiction by targeting reward pathways Among those prescribed these medications for obesity, many patients discontinued treatment before reaching what the authors describe as adequate therapeutic doses
Is there an oral GLP-1 agonist
With insurance, your cost may be as low as $25 per month, and qualifying individuals with Medicare Part D only pay $50 per month through the Medicare GLP-1 Bridge Program